About: Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.78 (-0.79%)
ACET NASDAQ Adicet Bio Inc
Adicet Bio Inc share price
Atividade de preço de ACET
Último preço
$ 3,780
Variação (24h)
-0,03 USD (0,79%)
Volume
155.66K
Volume (média 4 sem.)
-
Abertura
$ 3,80
Variação do dia
$ 3,71 - $ 3,86
Fechamento anterior
$ 3,81
Último negócio
28 Oct, 7:48 pm GMT+0
Atrasado
28 Oct, 7:48 pm GMT+0
ACET price performance
Atrasado
28 Oct, 7:48 pm GMT+0
quote.marketSignals